Suppr超能文献

内脏脂肪组织和炎症与超重和肥胖患者队列中肝酶升高相关。

Visceral adipose tissue and inflammation correlate with elevated liver tests in a cohort of overweight and obese patients.

机构信息

Department of Endocrinology, Antwerp University Hospital, University of Antwerp, Edegem, Belgium.

出版信息

Int J Obes (Lond). 2010 May;34(5):899-907. doi: 10.1038/ijo.2010.4. Epub 2010 Feb 9.

Abstract

OBJECTIVE

To study the relationship between elevated liver tests and high sensitive C-reactive protein (hs-CRP), as potential markers of liver inflammation and non-alcoholic steatohepatitis (NASH), with anthropometric and laboratory parameters in overweight patients, especially the relationship with visceral adipose tissue (VAT).

METHODS

Patients presenting to the obesity clinic were prospectively included. Detailed anthropometry, computed tomography (CT)-measured VAT, liver tests (aspartate transaminase (AST), alanine transaminase (ALT), alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT)) and hs-CRP were assessed, along with an extended series of biochemical parameters.

RESULTS

All 480 patients (gender distribution male (M)/female (F) (10/90%)) with complete data were included. Mean age was 39+/-13 years, mean BMI 34.5+/-6.0 kg m(-2). In 37.3% of the patients one or more of the liver tests were elevated. VAT was positively related to AST (r=0.18, P<0.001), ALT (r=0.29, P<0.001), ALP (r=0.16, P<0.01) and GGT (r=0.39, P<0.001). Comparing subjects with high (VAT>or=113 cm(2)) vs low (VAT<113 cm(2)) VAT levels, significant differences were noted for AST (26+/-12 vs 24+/-12 U l(-1), P=0.003), ALT (37+/-21 vs 31+/-21 U l(-1), P<0.001), ALP (76+/-20 vs 71+/-18 U l(-1), P=0.008), GGT (33+/-20 vs 25+/-15 U l(-1), P<0.001) and hs-CRP (0.62+/-0.43 vs 0.52+/-0.48 mg dl(-1), P<0.001). After correction for BMI the difference in AST and ALP between the high vs low VAT group disappeared. The differences for ALT and GGT remained significant (P=0.008 and P<0.001 respectively). After correction for hs-CRP the four different liver tests remained significantly higher in the high VAT group. A stepwise multiple regression analysis revealed that every single liver test has his own most important determinant; VAT and hs-CRP for AST, insulin resistance calculated with homeostasis model assessment (HOMA-IR) and hs-CRP for ALT and ALP, and triglycerides and VAT for GGT.

CONCLUSION

In overweight and obese patients, liver tests, especially ALT and GGT, are associated with visceral fat mass. After correction for BMI and hs-CRP, ALT and GGT are significantly higher in patients with increased VAT, thereby supporting evidence for a potential key role of VAT in the pathogenesis of non-alcoholic fatty liver disease (NAFLD).

摘要

目的

研究肝酶升高与高敏 C 反应蛋白(hs-CRP)之间的关系,hs-CRP 是肝脏炎症和非酒精性脂肪性肝炎(NASH)的潜在标志物,与超重患者的人体测量和实验室参数有关,尤其是与内脏脂肪组织(VAT)的关系。

方法

前瞻性纳入就诊于肥胖门诊的患者。评估详细的人体测量学、计算机断层扫描(CT)测量的 VAT、肝酶(天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、碱性磷酸酶(ALP)和γ-谷氨酰转移酶(GGT))和 hs-CRP,以及一系列扩展的生化参数。

结果

共纳入 480 例(性别分布为男性(M)/女性(F)(10/90%))患者,所有患者均具有完整数据。平均年龄为 39+/-13 岁,平均 BMI 为 34.5+/-6.0kg/m²。37.3%的患者存在一种或多种肝酶升高。VAT 与 AST(r=0.18,P<0.001)、ALT(r=0.29,P<0.001)、ALP(r=0.16,P<0.01)和 GGT(r=0.39,P<0.001)呈正相关。比较 VAT 水平较高(VAT>或=113cm²)和较低(VAT<113cm²)的患者,AST(26+/-12 与 24+/-12U l⁻¹,P=0.003)、ALT(37+/-21 与 31+/-21U l⁻¹,P<0.001)、ALP(76+/-20 与 71+/-18U l⁻¹,P=0.008)、GGT(33+/-20 与 25+/-15U l⁻¹,P<0.001)和 hs-CRP(0.62+/-0.43 与 0.52+/-0.48mg dl⁻¹,P<0.001)显著升高。校正 BMI 后,高 VAT 组和低 VAT 组之间的 AST 和 ALP 差异消失。ALT 和 GGT 差异仍有统计学意义(P=0.008 和 P<0.001)。校正 hs-CRP 后,高 VAT 组的四个不同肝酶仍显著升高。逐步多元回归分析显示,每个单独的肝酶都有其最重要的决定因素;AST 与 VAT 和 hs-CRP,ALT 和 ALP 与胰岛素抵抗的稳态模型评估(HOMA-IR)和 hs-CRP,GGT 与甘油三酯和 VAT。

结论

在超重和肥胖患者中,肝酶尤其是 ALT 和 GGT 与内脏脂肪量有关。校正 BMI 和 hs-CRP 后,VAT 增加的患者的 ALT 和 GGT 显著升高,从而支持 VAT 在非酒精性脂肪性肝病(NAFLD)发病机制中具有潜在关键作用的证据。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验